BACLE 发表于 2025-3-28 14:53:27

http://reply.papertrans.cn/24/2303/230213/230213_41.png

伪书 发表于 2025-3-28 21:15:28

http://reply.papertrans.cn/24/2303/230213/230213_42.png

不如乐死去 发表于 2025-3-28 22:56:22

http://reply.papertrans.cn/24/2303/230213/230213_43.png

ACRID 发表于 2025-3-29 05:13:30

http://reply.papertrans.cn/24/2303/230213/230213_44.png

cuticle 发表于 2025-3-29 09:15:41

http://reply.papertrans.cn/24/2303/230213/230213_45.png

安装 发表于 2025-3-29 12:15:22

http://reply.papertrans.cn/24/2303/230213/230213_46.png

follicle 发表于 2025-3-29 16:31:40

http://reply.papertrans.cn/24/2303/230213/230213_47.png

COWER 发表于 2025-3-29 23:22:24

http://reply.papertrans.cn/24/2303/230213/230213_48.png

foreign 发表于 2025-3-30 03:30:45

Paula Miranda,Pedro Isaias,Sara Pífanoanotechnology. Also, we described the importance of nanotechnology for imaging, diagnostic and monitoring of ocular diseases. Nanobiotechnology for glaucoma treatment, as well as nanoparticles for gene delivery therapy of retinal degenerative disease, is most attractive approach for the ophthalmological treatment.

Allergic 发表于 2025-3-30 07:13:31

http://reply.papertrans.cn/24/2303/230213/230213_50.png
页: 1 2 3 4 [5]
查看完整版本: Titlebook: Commercialization of Nanotechnologies–A Case Study Approach; Dermot Brabazon,Eva Pellicer,Kwang-Leong Choy Book 2018 Springer Internationa